Redeye adjusts its fair value range with a downward bias but continues to see meaningful upside to the share price, which was punished by the recent Q1 report.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases